UK regulators announce plans to upgrade pharmacovigilance systems, building on the MHRA’s Yellow Card scheme and lessons from the COVID‑19 pandemic. The Medicines and Healthcare products Regulatory Agency highlighted that digitising the Yellow Card reporting platform and integrating AI has enabled rapid analysis of large volumes of safety reports. The agency said that the upcoming Health Data Research Service will allow whole‑population data to be linked across the NHS using unique identifiers, facilitating near‑real‑time monitoring of drug safety. The initiative said the new system would support proactive detection of adverse events and help identify high‑risk sub‑populations. The initiative aims to position the UK as a world leader in next‑generation pharmacovigilance.
© Crown copyright, 2024, GOV.UK.
Summary adapted from content licensed under the Open Government Licence v3.0.
For details, see https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Original source: https://www.gov.uk/
https://www.gov.uk/government/news/professor-sir-aziz-sheikh-towards-next-generation-pharmacovigilance-capabilities-for-the-uk
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.